Recent research have focused on the convergence of GLP|GIP|glucagon receptor activator therapies and dopamine communication. While GCGR activators are widely employed for addressing type 2 diabetes, their potential impacts on reinforcement circuits, specifically mediated by dopaminergic networks, are attracting considerable attention. This repor… Read More